Corwin Dale Hooks
CIK: 0001665347
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 9, 2026SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectRestricted Stock Units
11K shares- - Feb 3, 2026APLT
Applied Therapeutics, Inc.
Disposition(D)Direct862.5K shares- - Feb 3, 2026APLT
Applied Therapeutics, Inc.
Tender Offer(U)Direct5.8K shares- - Dec 19, 2025APLT
Applied Therapeutics, Inc.
Award(A)Direct312.5K shares- - Mar 24, 2025APLT
Applied Therapeutics, Inc.
Award(A)Direct250K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 9, 2026 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Restricted Stock Units | 11,000 | - | - | Direct |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | Disposition(D) | 862,500 | - | $0 | Direct |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | Tender Offer(U) | 5,753 | - | $0 | Direct |
| Dec 19, 2025 | APLT Applied Therapeutics, Inc. | Award(A) | 312,500 | - | $0 | Direct |
| Mar 24, 2025 | APLT Applied Therapeutics, Inc. | Award(A) | 250,000 | - | - | Direct |
1-5 of 5 transactions
About Hooks Corwin Dale
Hooks Corwin Dale (SEC CIK 0001665347) files insider reports with the SEC as Chief Commercial Officer of SPRUCE BIOSCIENCES, INC. (SPRB) and Chief Commercial Officer of Applied Therapeutics, Inc. (APLT).
Signal8 holds 4 ownership filings by Hooks Corwin Dale (1 Form 3, 3 Form 4), filed between Mar 26, 2025 and Mar 9, 2026. Those filings report 5 transactions, from Mar 24, 2025 to Mar 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hooks Corwin Dale's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Hooks Corwin Dale
- Mar 9, 2026: Grant or award of SPRB derivative securities (Form 4, code A).
- Feb 3, 2026: Disposition to issuer transaction of APLT shares (Form 4, code D).
- Feb 3, 2026: Tender of shares transaction of APLT shares (Form 4, code U).
- Dec 19, 2025: Grant or award of APLT shares (Form 4, code A).
- Mar 24, 2025: Grant or award of APLT shares (Form 4, code A).
Other insiders filing for SPRUCE BIOSCIENCES, INC. (SPRB)
- Quartel Adrian W, Chief Medical Officer
- Szwarcberg Javier B., CHIEF EXECUTIVE OFFICER
- SPIEGELMAN DANIEL K, Director
- SIMPSON CAMILLA V, Director
- GREY MICHAEL G, Executive Chairman
- Barretto-Ko Percival, Director